
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
RABAPTIN-5 CRISPR/Cas9 KO Plasmid (h) | sc-403303 | 20 µg | $397.00 |
RABEP1 encodes RABAPTIN-5, a Rab5 effector that coordinates early endocytic trafficking by promoting vesicle tethering and fusion events on early endosomes. Through interactions with Rab5-family GTPases and endosomal sorting machinery, RABAPTIN-5 helps regulate receptor internalization, cargo recycling versus degradation decisions, and endosome maturation. These processes influence signaling output from surface receptors and the turnover of membrane proteins, linking RABEP1 function to pathways controlling growth factor signaling, nutrient uptake, and membrane homeostasis. Dysregulation of endocytic control and Rab5-dependent trafficking has been associated with altered signaling dynamics and cellular phenotypes observed in cancer biology and neurodegeneration-relevant models.
RABAPTIN-5 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the RABEP1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the RABEP1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the RABEP1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish RABAPTIN-5 protein expression.
This CRISPR knockout system enables efficient generation of RABEP1-deficient cell models for investigation of RABAPTIN-5 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.